Soga J
The Niigata Seiryo University, Niigata City, Niigata, Japan.
J Exp Clin Cancer Res. 2003 Mar;22(1):5-15.
This study was carried out to obtain extensive information on carcinoids (the carcinoid group) and related variant endocrinomas (the variant group) of the gallbladder, and to statistically analyze their characteristics from various clinicopathologic aspects. A total of 138 cases were collected from the international sources, 101 belonging to the carcinoid group and 37 to the variant group. The first group consisted of 81 cases of typical and 20 atypical carcinoids. Comparative evaluation was attempted mainly between the carcinoid and variant groups, and occasionally between the typical and atypical carcinoid series when statistical significance was suspected. The carcinoid group showed a statistically significant difference from the variant group by exhibiting a younger average age (61.7 years vs 69.7 years: P<0.01), a higher incidence of associated cholelithiasis (87.3% vs 56.0%: P<0.01), a higher incidence of small tumors 50 mm or less (85.2% vs 52.9%: P<0.01), a smaller average tumor-size (29.6 mm vs 58.7 mm: P<0.01), a lower rate of metastases (40.7% vs 70.6%: P<0.05), a higher immunoreactivity rate of chromogranin (100.0% vs 66.7%: P<0.01), a lower immunoreactivity rate of gastrin (23.8% vs 70.6%: P<0.01), and a higher five-year survival rate (60.4% vs 21.3%: P<0.0005). Significant differences in various clinicopathological aspects confirmed between the carcinoid group and the variant group suggested that endocrine carcinomas of these two groups perform a different clinical pattern, represented most clearly by postoperative outcomes. These groupings are decided on the basis of histologic patterns, namely, well to poorly differentiated endocrine carcinomas (typical to atypical carcinoids) and undifferentiated or anaplastic variants of other endocrine carcinomas. The basic criteria for such classification of these endocrine carcinomas based on international agreements are required.
本研究旨在获取关于胆囊类癌(类癌组)及相关变异内分泌肿瘤(变异组)的广泛信息,并从各种临床病理方面对其特征进行统计学分析。从国际资料中总共收集了138例病例,其中101例属于类癌组,37例属于变异组。第一组包括81例典型类癌和20例非典型类癌。主要尝试在类癌组和变异组之间进行比较评估,当怀疑有统计学意义时,偶尔也会在典型类癌系列和非典型类癌系列之间进行比较。类癌组与变异组相比,平均年龄更年轻(61.7岁对69.7岁:P<0.01),合并胆石症的发生率更高(87.3%对56.0%:P<0.01),肿瘤大小为50mm及以下的小肿瘤发生率更高(85.2%对52.9%:P<0.01),平均肿瘤大小更小(29.6mm对58.7mm:P<0.01),转移率更低(40.7%对70.6%:P<0.05),嗜铬粒蛋白免疫反应率更高(100.0%对66.7%:P<0.01),胃泌素免疫反应率更低(23.8%对70.6%:P<0.01),五年生存率更高(60.4%对21.3%:P<0.0005)。类癌组和变异组在各种临床病理方面的显著差异表明,这两组内分泌癌具有不同的临床模式,术后结果最为明显。这些分组是根据组织学模式确定的,即高分化至低分化内分泌癌(典型至非典型类癌)以及其他内分泌癌的未分化或间变变异型。需要基于国际共识制定这些内分泌癌分类的基本标准。